Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency
- PMID: 14985489
- DOI: 10.1056/NEJMra032207
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency
Comment in
-
LMO2 and gene therapy for severe combined immunodeficiency.N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. doi: 10.1056/NEJM200406103502422. N Engl J Med. 2004. PMID: 15190153 No abstract available.
-
LMO2 and gene therapy for severe combined immunodeficiency.N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. N Engl J Med. 2004. PMID: 15195349 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical